1. Home
  2. NBIX vs PNFP Comparison

NBIX vs PNFP Comparison

Compare NBIX & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

SELL

Current Price

$135.92

Market Cap

15.5B

Sector

Health Care

ML Signal

SELL

PNFP

Pinnacle Financial Partners Inc.

SELL

Current Price

$92.77

Market Cap

14.6B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
NBIX
PNFP
Founded
1992
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
15.5B
14.6B
IPO Year
1996
2025

Fundamental Metrics

Financial Performance
Metric
NBIX
PNFP
Price
$135.92
$92.77
Analyst Decision
Strong Buy
Buy
Analyst Count
29
22
Target Price
★ $206.81
$118.86
AVG Volume (30 Days)
★ 1.3M
1.1M
Earning Date
11-02-2026
10-21-2026
Dividend Yield
N/A
★ 2.14%
EPS Growth
★ 41.95
35.40
EPS
★ 3.30
2.96
Revenue
★ $161,626,000.00
N/A
Revenue This Year
$36.39
$145.52
Revenue Next Year
$16.93
$8.49
P/E Ratio
$40.95
★ $31.60
Revenue Growth
★ 977.51
N/A
52 Week Low
$122.14
$81.08
52 Week High
$186.12
$110.33

Technical Indicators

Market Signals
Indicator
NBIX
PNFP
Relative Strength Index (RSI) 32.66 37.96
Support Level $125.18 $81.76
Resistance Level $138.74 $99.77
Average True Range (ATR) 3.60 2.07
MACD -0.05 0.09
Stochastic Oscillator 22.43 16.85

Price Performance

Historical Comparison
NBIX
PNFP

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About PNFP Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.

Share on Social Networks: